Clinical utility of the combination of cognitive-behavioral techniques with nicotine patches as a smoking-cessation treatment: Five-year results of the “Ex-Moker” program

Group-based tobacco dependence treatment has been known to help smokers to quit in general adult populations, but the feasibility and efficacy of this type of smoking cessation treatment in correctional settings remain uncertain. A 6-week group-based smoking cessation treatment with nicotine replacement therapy (NRT) in the form of nicotine patches was implemented in seven male prison facilities, in the Northeast, among smokers who were born biologically as male. Exhaled breath carbon monoxide (CO) levels were collected from participants at each session to confirm smoking status. Participants were evaluated at the 1-month post-group treatment follow-up to determine abstinence. Those who were lost to follow-up were recorded as continued smoking and not using NRT nicotine patches. The goal of the study was to explore the feasibility and preliminary efficacy of conducting a smoking cessation treatment program for incarcerated smokers. A total of 350 inmates were screened, 177 inmates were enrolled across the prison sites for the 6-week program, and 102 inmates completed the program. A majority of those enrolled reported that they began smoking when they were between 15 and 19 years of age (44.9%) and were smoking on average for 26 years. Less than half (21.3%) reported ever using electronic cigarettes at baseline and in Session 1,116 individuals who attended reported a median CO level of 18.0 parts per million (ppm). At a 1-month follow-up, 43 individuals reported a median CO level of 5.00 ppm. The study demonstrated preliminary efficacy and feasibility of group-based smoking cessation treatment with NRT nicotine patches in incarcerated smokers.

Download Full-text

Nature and Role of Change in Anxiety Sensitivity During NRT-Aided Cognitive-Behavioral Smoking Cessation Treatment

Cognitive Behaviour Therapy ◽

10.1080/16506073.2011.632437 ◽

2012 ◽

Vol 41 (1) ◽

pp. 51-62 ◽

Cited By ~ 32

Author(s):

Yaara Assayag ◽

Amit Bernstein ◽

Michael J. Zvolensky ◽

Dan Steeves ◽

Sherry S. Stewart

Keyword(s):

Smoking Cessation ◽

Anxiety Sensitivity ◽

Cognitive Behavioral ◽

Smoking Cessation Treatment ◽

Cessation Treatment

Download Full-text

Evaluation of smoking cessation treatment initiated during hospitalization in patients with heart disease or respiratory disease

Jornal Brasileiro de Pneumologia ◽

10.1590/s1806-37562017000000026 ◽

2018 ◽

Vol 44 (1) ◽

pp. 42-48 ◽

Cited By ~ 1

Author(s):

Thaís Garcia ◽

Sílvia Aline dos Santos Andrade ◽

Angélica Teresa Biral ◽

André Luiz Bertani ◽

Laura Miranda de Oliveira Caram ◽

...

Keyword(s):

Health Care ◽

Smoking Cessation ◽

Heart Disease ◽

Hospital Discharge ◽

Respiratory Disease ◽

Health Care Professionals ◽

Smoking Cessation Program ◽

Cognitive Behavioral ◽

Smoking Cessation Treatment ◽

Cessation Treatment

ABSTRACT Objective: To evaluate the effectiveness of a smoking cessation program, delivered by trained health care professionals, in patients hospitalized for acute respiratory disease (RD) or heart disease (HD). Methods: Of a total of 393 patients evaluated, we included 227 (146 and 81 active smokers hospitalized for HD and RD, respectively). All participants received smoking cessation treatment during hospitalization and were followed in a cognitive-behavioral smoking cessation program for six months after hospital discharge. Results: There were significant differences between the HD group and the RD group regarding participation in the cognitive-behavioral program after hospital discharge (13.0% vs. 35.8%; p = 0.003); smoking cessation at the end of follow-up (29% vs. 31%; p < 0.001); and the use of nicotine replacement therapy (3.4% vs. 33.3%; p < 0.001). No differences were found between the HD group and the RD group regarding the use of bupropion (11.0% vs. 12.3%; p = 0.92). Varenicline was used by only 0.7% of the patients in the HD group. Conclusions: In our sample, smoking cessation rates at six months after hospital discharge were higher among the patients with RD than among those with HD, as were treatment adherence rates. The implementation of smoking cessation programs for hospitalized patients with different diseases, delivered by the health care teams that treat these patients, is necessary for greater effectiveness in smoking cessation.

Download Full-text

Evaluation of a web-based cognitive behavioral smoking cessation treatment for overweight/obese smokers

Journal of Health Psychology ◽

10.1177/1359105317701560 ◽

2017 ◽

Vol 24 (13) ◽

pp. 1796-1806 ◽

Cited By ~ 2

Author(s):

Marney A White ◽

Valentina Ivezaj ◽

Carlos M Grilo

Keyword(s):

Smoking Cessation ◽

Behavioral Treatment ◽

Standard Treatment ◽

Cognitive Behavioral ◽

Cognitive Behavioral Treatment ◽

Web Based ◽

Smoking Cessation Treatment ◽

Cessation Treatment ◽

Community Volunteers

This pilot study tested the efficacy of an Internet-administered smoking cessation treatment for overweight/obese smokers. Participants were 54 community volunteers with overweight/obesity who were regular smokers. Treatment consisted of 12 weeks of nicotine replacement therapy and randomization to Internet-administered cognitive behavioral treatment or health education. In-person assessments of key outcomes occurred at baseline, post-treatment, and at 24-week follow-up. Cessation rates did not differ across the two treatments (25.9% vs 18.5%). Participants receiving cognitive behavioral treatment gained less weight when abstinent than those receiving the standard treatment. Larger studies are needed to replicate these findings.

Download Full-text

Integrated Cognitive Behavioral Therapy for Anxiety and Smoking Cessation

Clinical Case Studies ◽

10.1177/1534650119859094 ◽

2019 ◽

Vol 18 (5) ◽

pp. 378-396

Author(s):

Julia D. Buckner ◽

Michael J. Zvolensky ◽

Katherine Walukevich-Dienst ◽

Elizabeth M. Lewis ◽

Kimberlye E. Dean ◽

...

Keyword(s):

Smoking Cessation ◽

Anxiety Disorder ◽

Cognitive Behavioral Therapy ◽

Anxiety Disorders ◽

Behavioral Therapy ◽

Cognitive Behavioral ◽

Safety Behavior ◽

Smoking Cessation Treatment ◽

Diagnostic Threshold ◽

Cessation Treatment

Smokers suffer from high rates of anxiety disorders, presumably because some individuals with anxiety disorders rely on smoking as a maladaptive attempt to manage anxiety. Cognitive behavioral therapy (CBT) is an efficacious smoking cessation treatment, yet outcomes are worse for patients with elevated anxiety. The integration of CBT for smoking cessation with False Safety Behavior Elimination Therapy (FSET) may be useful with anxious smoking cessation patients, as smoking to manage anxiety and associated negative affect can be targeted as a false safety behavior (i.e., behavior aimed at decreasing anxiety in the short-term but which may maintain or exacerbate it in the long-term). Here, we describe the integrated treatment, Treatment for Anxiety and Smoking Cessation (TASC), and the successful use of it with two smoking cessation patients—one with comorbid generalized anxiety disorder (GAD) and one with clinically elevated social anxiety that did not meet diagnostic threshold for an anxiety disorder. Data support the feasibility of TASC as a viable approach to smoking cessation treatment for patients with comorbid anxiety disorder and with elevated anxiety that does not meet diagnostic threshold. Future controlled trials are now warranted to further evaluate the intervention.

Download Full-text